跳至主要内容
临床试验/NCT06490211
NCT06490211招募中不适用

The Research Value of Multi-omics and Multi-modal Information in the Diagnosis and Treatment of Urinary System Tumors

Wuhan Union Hospital, China1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年11月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
1
主要终点
progression-free survival

研究概览

简要总结

Obtain puncture or surgically removed tumor tissue samples from patients with urinary tract tumors and perform RNA-sequencing, Single-cell RNA-sequence, Spatial Transcriptomics, Proteomics, and Intratumoral Microbiome.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients were treated for bladder cancer, kidney cancer, and prostate cancer in Wuhan Union Hospital from January 2024 to January 2026;
  • Aged > 18 years old;
  • Urinalysis, urine exfoliated cells, ultrasound, CT, and MR examinations indicated the above tumors;
  • Tissue biopsy pathological examination confirmed the diagnosis of the above tumors.

排除标准

  • Poor image quality;
  • Incomplete clinical data or loss of follow-up;
  • Presence of another primary malignant tumor other than urinary tract tumor;
  • Unclear pathological diagnosis

结局指标

主要结局

progression-free survival

时间窗: 2 years

次要结局

未报告次要终点

研究者

发起方
Wuhan Union Hospital, China
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验